As of 2026-03-22, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -4.58 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.11 USD, the upside of Sana Biotechnology Inc is -247.37%.
Based on its market price of 3.11 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 247.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.58 - -4.58 | -4.58 | -247.37% |
| P/E | (20.31) - (24.07) | (22.43) | -821.4% |
| DDM - Stable | (6.15) - (23.14) | (14.65) | -571.0% |
| DDM - Multi | (4.79) - (15.03) | (7.39) | -337.5% |
| Market Cap (mil) | 828.41 |
| Beta | 2.46 |
| Outstanding shares (mil) | 266.37 |
| Enterprise Value (mil) | 756.54 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.00% |
| Cost of Debt | 5.00% |
| WACC | 7.33% |